Scientific and Medical Equipment House Company (4014.SR)
SAR 41.3
(0.12%)
SAR 41.3
(0.12%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 19.84 Million SAR | -2.16% |
| 2022 | 20.28 Million SAR | 56.05% |
| 2021 | 12.99 Million SAR | 114.99% |
| 2020 | 6.04 Million SAR | 64.69% |
| 2019 | 3.67 Million SAR | 0.0% |
| 2018 | - SAR | 0.0% |
| 2017 | - SAR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.17 Million SAR | -13.81% |
| 2024 Q1 | 8.32 Million SAR | 0.0% |
| 2023 Q4 | 19.84 Million SAR | -15.82% |
| 2023 FY | 19.84 Million SAR | -2.16% |
| 2023 Q3 | 23.57 Million SAR | -3.54% |
| 2023 Q2 | 24.43 Million SAR | -2.09% |
| 2023 Q1 | 24.96 Million SAR | 23.08% |
| 2022 Q3 | 15.3 Million SAR | -7.81% |
| 2022 Q2 | 16.59 Million SAR | 0.03% |
| 2022 FY | 20.28 Million SAR | 56.05% |
| 2022 Q1 | 16.59 Million SAR | 27.67% |
| 2022 Q4 | 20.28 Million SAR | 32.55% |
| 2021 Q2 | 11.15 Million SAR | 0.0% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 FY | 12.99 Million SAR | 114.99% |
| 2021 Q4 | 12.99 Million SAR | 0.0% |
| 2020 FY | 6.04 Million SAR | 64.69% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 Q4 | 6.04 Million SAR | 0.0% |
| 2020 Q3 | 6.04 Million SAR | 0.0% |
| 2019 FY | 3.67 Million SAR | 0.0% |
| 2018 FY | - SAR | 0.0% |
| 2017 FY | - SAR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|